Citations

Clear

4 citation(s) found for "Sharma, Shweta".

Abstract TU205: The Effect of Physical Activity on the Gut Microbiome in Prediabetes: Results from a Randomized Controlled Trial
Demmer, Ryan, Pope, Zachary, Avenido, Francis Ryan, Mitchell, Nathan, Hubbard, Paige Richmond, Johnson, Stephen, McDonough, DJ, Rydell, Sarah, Johnson, Abigail, Pereira, Mark, Demmer, Ryan T. , Pope, Zachary , Mitchell, Nathan R , Hubbard, Paige F. Richmond, Johnson, Stephen, Sharma, Shweta , Rydell, Sarah A.

Mayo Clinic

Circulation | April 30, 2026 | Volume: 153 | Issue: Suppl_1 | Pages: No page available

10.1161/cir.153.suppl_1.tu205 Get It

Objective: To test the effect of physical activity on the gut microbiome and circulating short chain fatty acids among sedentary overweight/obese adults with prediabetes. We hypothesized that randomization to increased physical activity would result in gut microbiome changes. Methods: \We randomized 77 adults with prediabetes and a sedentary lifestyle into one of two groups: 1) Intervention Group: Invited to engage in home-based moderate intensity walking 3x/week for 30 minutes/session in weeks 1-4 and for 45 minutes/session during weeks 5-8 of the 8-week intervention; or 2) Control Group: Maintained habitual physical activity levels. We performed metagenomic sequencing from stool collected at baseline, week 4, and week 8, with short-chain fatty acids (SCFA) measured from serum collected at baseline and week 8. Taxonomic and functional profiling were performed on the metagenomic reads; alpha diversity metrics were subsequently derived. Linear regression assessed the difference in change between the intervention and control groups for alpha-diversity and SCFA levels. Results: We screened 1,533 participants for eligibility and consented 132. Of these, 87 entered the run-in phase and 77 were randomized. Participants were 51.4±8.9 years old, 87.7% female, and 74% non-Hispanic White. Mean fasting glucose was 103.3±13.2 while mean BMI was 34.4±5.7. In comparison to the control group, the intervention group experienced decreased alpha diversity as characterized by Shannon, Richness, and Faith’s diversity indices by week 8 of the intervention (P<0.05). SCFA levels trended towards improvement in the intervention group, but the results were not statistically significant. Functional analysis of KEGG ontologies revealed themes consistent with a microbiome with enhanced metabolic activity and host-relevant metabolic signaling (Figure). Conclusions: Randomization to a walking intervention resulted in modest gut microbiome changes among adults with overweight/obesity and prediabetes.
The Effect of Physical Activity on the Gut Microbiome in Prediabetes: Results From a Randomized Controlled Trial
Avenido, Francis Ryan R., Mitchell, N. Reed, Hubbard, Paige F. Richmond, Johnson, Stephen, Sharma, Shweta, McDonough, Daniel J. , Rydell, Sarah A. , Pereira, Mark, Pereira, Mark A. , Sharma, Shweta , McDonough, Daniel J , Pereira, Mark A , Demmer, Ryan T. , Pope, Zachary , Avenido, Francis Ryan, Johnson, Stephen, Johnson, Abigail J.

Mayo Clinic

Diabetes Obesity and Cardiometabolic CARE | March 16, 2026 | Volume: 1 | Issue: 2 | Pages: 219-229

10.2337/doc25-0067 | PMID 42577916 Get It

OBJECTIVE To test the effect of physical activity on the gut microbiome and circulating short-chain fatty acids (SCFAs) among sedentary adults with prediabetes and overweight or obesity. RESEARCH DESIGN AND METHODS In a pilot and feasibility trial, we randomized 77 adults with prediabetes and a sedentary lifestyle into one of two groups: 1) intervention: invited to engage in home-based moderate-intensity walking 3×/week for 30 min/session in weeks 1–4 and for 45 min/session during weeks 5–8 of the 8-week intervention; or 2) control: maintained habitual physical activity levels. We performed metagenomic sequencing from stool collected at baseline, week 4, and week 8, with SCFAs measured from serum collected at baseline and week 8. Taxonomic and functional profiling was performed on the metagenomic reads; α-diversity metrics were subsequently derived. Linear regression assessed the difference in change between the intervention and control groups for α-diversity and SCFA levels. RESULTS We screened 1,533 participants for eligibility and consented 132. Of these, 87 entered the run-in phase, and 77 were randomized. Participants were mean (SD) 51.4 (8.9) years old, 87.7% female, and 74% non-Hispanic White. Mean fasting glucose was 103.3 (13.2) mg/dL, while mean BMI was 34.4 (5.7) kg/m2. Compared with the control group, the intervention group experienced decreased α-diversity as characterized by Shannon, Richness, and Faith diversity indices by intervention week 8 (P &lt; 0.05). Changes in SCFA levels were not statistically significant different in intervention versus control. CONCLUSIONS Randomization to a walking intervention resulted in modest gut microbiome changes among adults with overweight or obesity and prediabetes.
The Effects of Aspirin Intervention on Inflammation-Associated Lingual Bacteria: A Pilot Study from a Randomized Clinical Trial
Onyeaghala, Guillaume C. , Sharma, Shweta , Oyenuga, Mosunmoluwa , Staley, Christopher , Demmer, Ryan T. , Thyagarajan, Bharat , Straka, Robert J. , Church, Timothy R. , Prizment, Anna E. , Staley, Christopher M , Thyagarajan, Bharat , Straka, Robert J , Church, Timothy R , Prizment, Anna E , Demmer, Ryan T , Milne, Ginger L. , Shaukat, Aasma

Mayo Clinic

Microorganisms | August 7, 2024 | Volume: 12 | Issue: 8 | Pages: 1609

10.3390/microorganisms12081609 | PMID 39203451 Get It

Several bacterial taxa enriched in inflammatory bowel diseases and colorectal cancer (CRC) are found in the oral cavity. We conducted a pilot study nested within a six-week aspirin intervention in a randomized placebo-controlled trial to test their response to aspirin intervention. Fifty healthy subjects, 50–75 years old, were randomized to receive 325 mg aspirin (n = 30) or placebo (n = 20) orally once daily for six weeks. Oral tongue swabs were collected at baseline and week six. We estimated the association between aspirin use and the temporal changes in the relative abundance of pre-specified genus level taxa from pre- to post-treatment. The temporal change in relative abundance differed for eight genus level taxa between the aspirin and placebo groups. In the aspirin group, there were significant increases in the relative abundances of Neisseria, Streptococcus, Actinomyces, and Rothia and significant decreases in Prevotella, Veillonella, Fusobacterium, and Porphyromonas relative to placebo. The log ratio of Neisseria to Fusobacterium declined more in the aspirin group than placebo, signaling a potential marker associated with aspirin intervention. These preliminary findings should be validated using metagenomic sequencing and may guide future studies on the role of aspirin on taxa in various oral ecological niches.
Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment Trial
Arenas‐Pinto, Alejandro , Grund, Birgit , Sharma, Shweta , Martínez, Estebán , Fox, Julie , Klingman, Karin L. , Collins, Simon , Flynn, Patricia M. , Chasanov, William M, Kedem, Eynat, Katlama, Christine , Sierra‐Madero, Juan , Brouwers, Pim , Cooper, David A., group, INSIGHT START study, Cummins, Nathan, Cummins, Nathan W. , Sedláček, Dalibor , Afonso, Cláudia M. , group, INSIGHT START study

Mayo Clinic

Clinical Infectious Diseases | February 1, 2018 | Volume: 67 | Issue: 3 | Pages: 420-429

10.1093/cid/ciy051 | PMID 29538636 Get It